Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.34 - $2.08 $1 - $2
1 New
1 $0
Q1 2022

May 16, 2022

SELL
$1.1 - $2.17 $2 - $4
-2 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.99 - $3.1 $1,751 - $2,728
-880 Reduced 99.77%
2 $0
Q2 2021

Aug 16, 2021

BUY
$2.56 - $3.35 $2,257 - $2,954
882 New
882 $3,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.